Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in NURIX THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 168,843 shares of NRIX (NURIX THERAPEUTICS INC), worth $3.2M as of 2025-Q4. The position was increased (++72.0% shares). NRIX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.2M
Current Shares
168,843
Total Value Change
+$517,587
Total Shares Change
+40,172
Other major holders of NRIX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, BlackRock, Inc., BlackRock Finance, Inc.
Increased |
| 168,843 |
+72.0% |
| $3.2M |
| 0.0% |
| $19.02 |
40 |
| 2025-Q3 | Decreased | 98,145 | -57.7% | $906,860 | 0.0% | $9.28 | 0 |
| 2025-Q2 | Increased | 232,055 | +45.5% | $2.6M | 0.0% | $11.64 | 36 |
| 2025-Q1 | Increased | 159,530 | +8.7% | $1.9M | 0.0% | $12.15 | 28 |
| 2024-Q4 | Increased | 146,713 | +14.2% | $2.8M | 0.0% | $18.64 | 30 |
| 2024-Q3 | Decreased | 128,524 | -0.1% | $2.9M | 0.0% | $23.05 | 0 |
| 2024-Q2 | New | 128,671 | - | $2.7M | 0.0% | $20.87 | 36 |